Integration of Newly Approved Diagnostics - What You'd Expect is in the Way...

68% of clinicians cite insurance restrictions and prior authorization delays as their primary roadblock.

Boston MA -- September 22: For frontline clinicians, the bottleneck in women's healthcare is no longer a lack of medical innovation.

According to the Women's Health Infrastructure Report 2026, providers find themselves increasingly trapped between evolving standards of care and antiquated utilization management.

Insurance gates (68%) vastly eclipse internal operational issues like hospital procurement (16%) or lack of EHR integration (5%).

"This is where the divergence between clinical evidence and HEOR becomes consequential. HEOR has not yet developed a sufficiently standardized methodology for translating clinical advancement into payer-relevant value... Developing that translational bridge is now an immediate need if reimbursement frameworks are to keep pace with clinical innovation."

J.J. Marx

CEO, Foravisét

This finding represents just one of dozens of insights uncovered through the Women's Health Infrastructure Report 2026, a cross-sector study bringing together perspectives from health plans, providers, employers, clinicians, life sciences organisations and innovators.

The full report features detailed findings, expert commentary, benchmark data and practical implications for healthcare leaders looking to understand where women's health is heading next.

Lead Research Partner